Market Overview The global intravenous immunoglobulin market was valued at USD 12.66 billion in 2023 and is expected to grow at a CAGR of 7.50% during the forecast period. IVIG therapy plays a critical role in treating a wide range of immune-related disorders, including primary immunodeficiencies, chronic inflammatory demyelinating polyneuropathy (CIDP), immune thrombocytopenia (ITP), and other...